BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17593339)

  • 1. [High intensity focused pulsed ultrasound (HIFU) for local ablation of prostate carcinoma].
    Thüroff S; Chaussy C
    Urologe A; 2007 Sep; 46(9):1092. PubMed ID: 17593339
    [No Abstract]   [Full Text] [Related]  

  • 2. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
    Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
    Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of color Doppler in guiding prostate biopsy after HIFU ablation.
    Rouvière O; Mège-Lechevallier F; Chapelon JY; Gelet A; Bouvier R; Boutitie F; Lyonnet D
    Eur Urol; 2006 Sep; 50(3):490-7. PubMed ID: 16439055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
    Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles and results of high-intensity focused ultrasound for localized prostate cancer.
    Colombel M; Gelet A
    Prostate Cancer Prostatic Dis; 2004; 7(4):289-94. PubMed ID: 15452554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer.
    Sumitomo M; Asakuma J; Sato A; Ito K; Nagakura K; Asano T
    Int J Urol; 2010 Nov; 17(11):924-30. PubMed ID: 20969640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-intensity focused ultrasound: a potential salvage treatment for recurrent prostate cancer following radiotherapy.
    Acher PL; Thwaini A; Shergill IS; Barua JM
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):969-70. PubMed ID: 16831068
    [No Abstract]   [Full Text] [Related]  

  • 9. Salvage radiotherapy after high-intensity focussed ultrasound for recurrent localised prostate cancer.
    Riviere J; Bernhard JC; Robert G; Wallerand H; Deti E; Maurice-Tison S; Ardiet JM; Maire JP; Richaud P; Ferriere JM; Ballanger P; Gelet A; Pasticier G
    Eur Urol; 2010 Oct; 58(4):567-73. PubMed ID: 20598436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonablate-500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer.
    Illing R; Emberton M
    Expert Rev Med Devices; 2006 Nov; 3(6):717-29. PubMed ID: 17280536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Locally recurrent prostatic adenocarcinoma after exclusive radiotherapy: results of high intensity focused ultrasound].
    Poissonnier L; Murat FJ; Belot A; Bouvier R; Rabilloud M; Rouviere O; Chapelon JY; Gelet A
    Prog Urol; 2008 Apr; 18(4):223-9. PubMed ID: 18501302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current role of high-intensity focused ultrasound for the management of radiation-recurrent prostate cancer.
    Sountoulides P; Theodosiou A; Finazzi-Agró E
    Expert Rev Med Devices; 2012 Jul; 9(4):401-8. PubMed ID: 22905844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HIFU in urological oncology].
    Thüroff S; Chaussy C
    Urologe A; 2008 Apr; 47(4):431-2, 434-8, 440. PubMed ID: 18351319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anterior perirectal fat tissue thickness is a strong predictor of recurrence after high-intensity focused ultrasound for prostate cancer.
    Sumitomo M; Asakuma J; Yoshii H; Sato A; Horiguchi A; Ito K; Nagakura K; Asano T
    Int J Urol; 2010 Sep; 17(9):776-82. PubMed ID: 20569272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients.
    Crouzet S; Rebillard X; Chevallier D; Rischmann P; Pasticier G; Garcia G; Rouviere O; Chapelon JY; Gelet A
    Eur Urol; 2010 Oct; 58(4):559-66. PubMed ID: 20619958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elastography for the follow-up of high-intensity focused ultrasound prostate cancer treatment: initial comparison with MRI.
    Curiel L; Souchon R; Rouvière O; Gelet A; Chapelon JY
    Ultrasound Med Biol; 2005 Nov; 31(11):1461-8. PubMed ID: 16286025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy.
    Hayashi M; Shinmei S; Asano K
    Int J Urol; 2007 Nov; 14(11):1048-50. PubMed ID: 17956536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transurethral resection of prostate just following high intensity focused ultrasound in localized prostate cancer--trial for early removal of the urethral catheter].
    Otsuki H; Sumitomo M; Umeda S; Shirotake S; Tobe M; Ito K; Asano T; Nagakura K; Hayakawa M
    Hinyokika Kiyo; 2008 Mar; 54(3):189-95. PubMed ID: 18411774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device].
    Aliaev IuG; Krupinov GE; Bezrukov EA; Grigorian VA; Amosov AV; Chalyĭ ME; Kobzev DN; Bruk IuF; Shestiperov PA
    Urologiia; 2007; (6):39-44. PubMed ID: 18649659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on the interpolation algorithm for the serial-parallel robot-controlled HIFU].
    Yu DY; Luo F; Fan LZ
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Jul; 30(4):241-4. PubMed ID: 17039926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.